Dogwood Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.51K Sell
18
-3
-14% -$622 ﹤0.01% 569
2026
Q1
$4.71K Buy
21
+15
+250% +$3.74K ﹤0.01% 488
2025
Q4
$1.45K Buy
6
+1
+20% +$256 ﹤0.01% 604
2025
Q3
$1.37K Hold
5
﹤0.01% 573
2025
Q2
$1.28K Sell
5
-4
-44% -$954 ﹤0.01% 601
2025
Q1
$2.02K Buy
+9
New +$2.1K ﹤0.01% 339
2024
Q3
Hold
0
370
2024
Q2
Hold
0
442
2024
Q1
Hold
0
436
2023
Q4
Hold
0
425

Other funds holding RMD

Dogwood Wealth Management's RMD Position: Q2 2026 in Review

Dogwood Wealth Management reduced its ResMed (RMD) stake by 14% in Q2 2026, selling an estimated $622 and leaving 18 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Dogwood Wealth Management first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.71K in Q1 2026. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Dogwood Wealth Management held 18 shares of ResMed worth $3.51K as of Q2 2026.
  • Dogwood Wealth Management sold 3 ResMed shares in Q2 2026, an estimated $622.
  • ResMed made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #569 holding.
  • Dogwood Wealth Management first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • Dogwood Wealth Management's ResMed position peaked at $4.71K in Q1 2026.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.